Arikayce (amikacin liposome inhalation suspension) / Insmed  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Arikayce (amikacin liposome inhalation suspension) / Insmed
NCT06238856: Single Dose Escalation Study of TR02 (Sustained Lipid Inhalation Technology [SLIT™] Amikacin) in Participants With Cystic Fibrosis (CF) Having Chronic Infections of Pseudomonas Aeruginosa

Completed
1
18
NA
SLIT™ Amikacin, TR02, Placebo
Insmed Incorporated
Cystic Fibrosis
02/05
02/05
NCT05999942: A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male Participants

Completed
1
6
NA
Liposomal Amikacin for Inhalation, Amikacin Liposome Inhalation Suspension (ALIS),, Arikayce™
Insmed Incorporated
Healthy Volunteers
06/04
06/04

Download Options